Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

AMGN US Equity

Amgen IncHealth Care · Biological Products, (No Diagnostic Substances) · CIK 318154 · FY ends Dec 31
$442.36
+17.08 (+4.02%)
USD · as of 2026-08-19 · marketstack
10 8-K filings · 0 13D · 4 13G
DateEventWhat happened / filerSource
2026-08-048-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-318-K 1.05Material cybersecurity incidentsec.gov ↗
2026-05-208-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-198-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-05-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Capital World Investorssec.gov ↗
2026-04-308-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-04-2913GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-04-228-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-03-2613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-02-198-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-02-038-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-01-308-K 1.02Termination of a material definitive agreementsec.gov ↗
2025-11-048-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-09-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-09-08

Every row is a filed document, checked against its EDGAR index.